Delivery Order SPE2DB22D3016-SPE2DB24FASE6
Award Date 4/10/24
Potential Completion Date 4/11/24
Potential Value $1.4K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is a firm fixed price delivery order for 4,564,096,537 tablets of Metformin Hydrochloride 1,000 mg with a ceiling value of $1,648.50. The contract has an ultimate completion date of March 28, 2024. Amerisourcebergen Drug Corp holds an...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,022.00 Firm Fixed Price Delivery Order is for the supply of 4,564,909,241 units of Metformin HCl ER 500 mg tablets. The award has an ultimate completion date of June 17, 2024 and was made on June 14, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, worth $3,738.34, is for the delivery of Metformin ER 1,000 mg tablets in 60-count packages. It is a firm fixed-price delivery order contract with an ultimate completion date of April 9, 2025. The contract is not set aside for any specific business type. AmerisourceBergen holds a larger $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $38,573.49 firm fixed-price delivery order is for the supply of 4,566,776,139 units of Metformin HCL 500 mg tablets. The contract has an ultimate completion date of December 23, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,825.69 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 4,564,179,958 tablets of Metformin HCl ER 500 mg. This delivery order was issued under an existing indefinite delivery contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA. The IDC serves as the primary contract vehicle for AmerisourceBergen to deliver...
- The Defense Logistics Agency awarded a delivery order valued at $1,596.30 to AmerisourceBergen Drug Corp for the supply of Metformin HCL ER 500 mg tablets (1,000 count) on April 24, 2025, with an ultimate completion date of April 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of...
- This federal contract award to AmerisourceBergen Drug Corporation is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 through November 2026. The delivery order is for the pharmaceutical product Metformin ER 1,000 mg osmotic-release tablets, in quantities of 60 per bottle. The contract has a firm fixed price of $3,899.30 and a completion date of December 2, 2024. This contract...
- This federal contract award, with ID SPE2DB20D7066|SPE2DB25FC3BE, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,050.98 firm fixed-price delivery order is for the supply of 4,567,930 units of Metformin HCL ER 750 mg tablets, a medication used to treat diabetes. The contract has an ultimate completion date of April 17, 2025 and is not set aside for a specific business type....
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is for the delivery of 4,564,184,816 units of Metformin HCL ER 500 mg tablets with a ceiling value of $6,994.15. The delivery order has an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and has previously received numerous...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $15,218.45, is for the delivery of 4,560,801,842 units of Metformin HCL ER 500 mg tablets. It is a firm fixed-price delivery order contract with a completion date of May 3, 2023. The contract was awarded on May 2, 2023, and there was no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB24FASE6Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of Metformin HCL ER 750 mg tablets to the Defense Logistics Agency (DLA) under a firm fixed price delivery order. The award, valued at $1,364.22, has an ultimate completion date of April 11, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This award is not associated with any set-aside designation.
Generated 7/10/24, 10:08 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 4/10/24 |